Genuity Science
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$15.0m | Series A | ||
N/A | Acquisition | ||
$75.0m | Series B | ||
$165m | Series B | ||
$200m | Series C | ||
$100m Valuation: $100m | Acquisition | ||
Total Funding | €414m |
Recent News about Genuity Science
EditGenuity Science operates in the precision health sector, focusing on genomics to transform healthcare. The company collaborates with hospitals, advocacy groups, academic institutions, and research centers to understand how genetics, environment, and lifestyle influence disease prevention and treatment. By leveraging groundbreaking research, Genuity Science aims to predict, prevent, and treat diseases more precisely, thereby improving lives. The company serves a diverse range of clients, including healthcare providers, researchers, and patients, particularly those with undiagnosed disorders. Its business model revolves around conducting research studies and providing whole genome sequencing services, especially for rare diseases. Revenue is generated through partnerships, research grants, and service fees. Genuity Science is committed to advancing medical breakthroughs and reimagining the future of healthcare.
Keywords: genomics, precision health, disease prevention, healthcare transformation, research collaboration, whole genome sequencing, rare diseases, medical breakthroughs, healthcare providers, academic partnerships.